SOUTH KOREA · OPENDART
DAEWON PHARMACEUTICAL CO.,LTD
대원제약 · 003220 · KOSPI · Healthcare · Drug Manufacturers—Specialty & Generic
Score
Not ranked: no net buying on the exchange by an individual insider in the last 180 days.
Insiders' buying price vs the latest close
Insiders paid 10,259.50 KRW a share on average (2 purchase lines, 1 buyer, 2026-03-09 – 2026-03-10). The close on 2026-10-16 was 23.2% below that price.
The latest purchase (2026-03-10) was at 10,240.00 KRW; the close was 23.0% below that price.
Prices paid are weighted by shares and taken from the filings; dividends are not counted. Not scored.
Insider trades on the exchange
Purchases and sales on the exchange in the last 12 months. The filing gives the settlement date; the trade date is two trading days earlier.
Other changes in holdings · 2
Option exercises, grants, new shares, inheritance, gifts, off-exchange trades and trades by companies and funds. Not counted in the score.